Generated: November 19, 2017
DrugPatentWatch Database Preview
RAVOCAINE AND NOVOCAIN W/ LEVOPHED Drug Profile
What is the patent landscape for Ravocaine And Novocain W/ Levophed, and what generic Ravocaine And Novocain W/ Levophed alternatives are available?
Ravocaine And Novocain W/ Levophed
is a drug marketed by Eastman Kodak and is included in one NDA.
The generic ingredient in RAVOCAINE AND NOVOCAIN W/ LEVOPHED is norepinephrine bitartrate; procaine hydrochloride; propoxycaine hydrochloride. There are four drug master file entries for this compound. Additional details are available on the norepinephrine bitartrate; procaine hydrochloride; propoxycaine hydrochloride profile page.
Summary for RAVOCAINE AND NOVOCAIN W/ LEVOPHED
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.